A recurrent synonymous mutation in the human androgen receptor gene causing complete androgen insensitivity syndrome

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Citação
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, v.174, p.14-16, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Androgen insensitivity syndrome (AIS) is the most common cause of 46,XY disorders of sex development (46,XY DSD). This syndrome is an X-linked inheritance disease and it is caused by mutations in the human androgen receptor (AR) gene. Non-synonymous point AR mutations are frequently described in this disease, including in the complete phenotype. We present a novel synonymous mutation in the human AR gene (c.1530C > T) in four 46,XY patients from two unrelated families associated with complete androgen insensitivity syndrome (CAIS). The analysis of mRNA from testis showed that synonymous AR mutation changed the natural exon 1 donor splice site, with deletion of the last 92 nucleotides of the AR exon 1 leading to a premature stop codon 12 positions ahead resulting in a truncate AR protein. Linkage analyses suggested a probable founder effect for this mutation. In conclusion, we described the first synonymous AR mutation associated with CATS phenotype, reinforcing the disease-causing role of synonymous mutations
Palavras-chave
Androgen receptor, Androgen insensitivity syndrome, Synonymous mutations, DSD 46,XY, Complete androgen insensitivity, Disorders of sexual development
Referências
  1. Achermann JC, 2015, NAT REV ENDOCRINOL, V11, P478, DOI 10.1038/nrendo.2015.69
  2. Appari M, 2009, J MOL MED, V87, P623, DOI 10.1007/s00109-009-0462-3
  3. Arnhold IJP, 2011, ADV EXP MED BIOL, V707, P59, DOI 10.1007/978-1-4419-8002-1_14
  4. Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011
  5. Chamary JV, 2009, SCI AM, V300, P46
  6. Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046
  7. Hellwinkel OJC, 2001, J CLIN ENDOCR METAB, V86, P2569, DOI 10.1210/jc.86.6.2569
  8. Hiort O, 2013, ENDOCR DEV, V24, P33, DOI 10.1159/000342499
  9. Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006
  10. Melo KFS, 2003, J CLIN ENDOCR METAB, V88, P3241, DOI 10.1210/jc.2002-021658
  11. Simhadri VL, 2017, J MED GENET, V54, P338, DOI 10.1136/jmedgenet-2016-104072
  12. Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051
  13. Zheng SY, 2014, CELL, V156, P1129, DOI 10.1016/j.cell.2014.02.037